Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.9.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.9.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.16.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.16.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.76ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.76ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.76NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
FL.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.107ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.107ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.107ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.107NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LF.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LF.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used